#$%^&*AU2012258339A120130627.pdf#####New Combination Between 4-{3-[Cis-hexahydrocyclopenta[c]pyrrol2(1H)-yl]propoxy}benzamide and an NMDA Receptor Antagonist, and Pharmaceutical Compositions Containing It Abstract A combination between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide of formula (I): H H / / N H2 or an addition salt thereof with a pharmaceutically acceptable acid or base, and an NMDA glutamatergic receptor antagonist. Medicaments are also disclosed.